World Health Organization Raises Concern Over Severe Scarcity of Weight-Loss Medications
Less than 10% of people who could benefit from weight-loss injections like Wegovy can access them, states the WHO as it publishes its inaugural recommendations on the drugs.
With over a billion people worldwide now obese, it is advocating for broader and more equitable access to GLP-1 medication.
Per forecasts, over two billion are projected to be living with obesity by 2030 without intervention.
"Our latest guidance affirms that obesity is a long-term condition that can be treated with holistic and continuous care," remarked WHO director-general Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and distribution challenges are key hurdles to universal availability to the jabs that can assist patients in reducing significant weight, explains the body.
Skinny Jab Shortage
Even under the current most favorable case, the manufacturing of such drugs could only cover approximately 100 million people – under 10% of those who need them, as stated by the WHO.
The recommendation urges governments and firms to increase availability, by measures including licensing agreements.
Exclusive production rights on a key compound – the primary component of a leading brand – is set to lapse in a number of nations in 2026.
How Obesity Drugs Operate
These medications replicate a natural hormone to slow digestion, reduce hunger and enhance the sense of being full so users reduce food intake.
Individuals commonly begin shedding pounds in the initial weeks of starting on the once-weekly jabs.
Studies points to users may regain a significant portion after a year of stopping the medication, because their usual food cravings come back.
To be carrying excess weight increases your likelihood for experiencing medical conditions, such as type 2 diabetes, cardiovascular issues, stroke, and specific malignancies.
Excess weight affects individuals in all nations and was responsible for over three and a half million deaths worldwide in 2024, as per the WHO.
